MedTrace Logo

Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study

NCT04634188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2020-11-18

No results posted yet for this study

Summary

This study is a case controlled analytical study that analyzes the relationship between levels of inflammatory markers with the type of brain tumor. Samples of 35 people were then categorized according to the variables above and analyzing to measure its significance

Conditions

Interventions

DIAGNOSTIC_TEST

Procalcitonin

Samples were categorized based on demographic data (age and gender), then the samples were categorized based on the type of brain tumor suffered. Once categorized, the levels of inflammatory markers was examined. Specimens were taken from the patient's peripheral blood examination and analyzed in laboratorium. The results of these examinations are grouped on a nominal scale, and analyzed statistically

Sponsors & Collaborators

  • Universitas Sumatera Utara

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-09-01
Completion
2020-10-01

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04634188 on ClinicalTrials.gov